Lupin said in a regulatory filing that the US health regulator had made two observations following the inspection and had classified the inspection as Official Action Indicated
from Latest News http://bit.ly/2K6dLfb
Monday, 27 May 2019
Lupin's Goa plant may face regulatory action, says USFDA after inspection
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment